Zhang et al. found that EZH2 inhibition, when paired with bromodomain and extra-terminal (BET) protein inhibition, suppressed H3K27M neural stem cells and significantly altered H3K27M-mutant tumor cell proliferation [54]. Here, EZH2 is linked to neoplasm.